Fast and sensitive chemiluminescence assay of aminophylline in human serum using luminol-diperiodatoargentate(III) system catalyzed by coated iron nanoparticles

Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
B RezaeiL Zarei

Abstract

The CL intensity of luminol-diperiodatoargentate(III) (DPA) system is strongly enhanced by addition of iron nanoparticles (FeNPs) covered with C12E4. On injection of aminophylline into luminol-DPA-FeNPs system, the CL intensity is significantly increased. On this basis, a sensitive CL assay was developed for determination of AmP in human serum. FeNPs could catalyze the oxidation rate of luminol in the present of oxygen. Also, the CL intensity of luminol-DPA-FeNPs system is significantly increased in the presence of aminophylline (AmP). Based on this ruling, a sensitive CL assay was developed for determination of AmP in human serum. The influences of analytical variables on the CL signal were studied and optimized. Under the optimum conditions in the present of FeNPs, the CL intensity is linearly increased with AmP concentration in the range of 1.0×10(-8)-2.0×10(-6) mol L(-1). The detection limit was 9.8×10(-9) mol L(-1) AmP and the relative standard deviation for ten parallel measurements of 8.0×10(-7)mol L(-1) AmP was also 4.8%. The proposed system was successfully applied to determine AmP in human serum samples.

Citations

May 23, 2012·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Xu HunYunhua He
Nov 6, 2012·Luminescence : the Journal of Biological and Chemical Luminescence·Mortaza Iranifam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.